Relation Between Safety Endpoints and Everolimus Trough Blood Level in Advanced Renal Cell Carcinoma
Condition(s):Renal Cell CarcinomaLast Updated:July 28, 2017Terminated
Hide Studies Not Open or Pending
Condition(s):Renal Cell CarcinomaLast Updated:July 28, 2017Terminated
Condition(s):Acute Myocardial InfarctionLast Updated:July 29, 2016Unknown status
Condition(s):Cervical Cancer; Cervical Intraepithelial; Neoplasia; CINLast Updated:March 13, 2020Completed
Condition(s):Seasonal Allergic RhinitisLast Updated:January 11, 2024Recruiting
Condition(s):Paroxysmal Atrial Fibrillation; Catheter Ablation StrategiesLast Updated:September 1, 2022Completed
Condition(s):Coronary RestenosisLast Updated:October 13, 2014Completed
Condition(s):Two Different Techniques to Perform Epidural Using UltrasoundLast Updated:April 14, 2020Unknown status
Condition(s):Prostate CancerLast Updated:January 5, 2024Active, not recruiting
Condition(s):Primary Central Nervous System LymphomaLast Updated:September 22, 2022Recruiting
Condition(s):Idiopathic Pulmonary FibrosisLast Updated:October 15, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.